| Patel, Ankit B |
| Completed | 3 | 804 | Canada, US, RoW | Simufilam, PTI-125, Placebo | Cassava Sciences, Inc., Premier Research Group plc | Alzheimer Disease | 10/24 | 10/24 | | |
TEJAS-2, NCT06760702: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients with Colorectal, Ovarian, and Renal Cancers |
|
|
| Recruiting | 2 | 90 | RoW | AUR109 200mg, AUR109 300mg, AUR109 400mg | Aurigene Discovery Technologies Limited | Ovarian Cancer, Colorectal Cancer, Renal Cancer | 09/26 | 05/27 | | |
| Recruiting | 1 | 42 | RoW | AUR104 | Aurigene Discovery Technologies Limited | Select Relapsed/Refractory Lymphoid Malignancies | 11/26 | 01/27 | | |
JIVAN, NCT05861947: A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies |
|
|
| Recruiting | 1 | 30 | RoW | AUR106 | Aurigene Discovery Technologies Limited | Relapse, Advanced Malignant Neoplasm, Non Small Cell Lung Cancer, Gastric Cancer, Urothelial Carcinoma, Kidney Cancer, Colon Cancer, Esophagus Cancer | 05/25 | 06/25 | | |
NCT05865002: A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) |
|
|
| Recruiting | 1 | 50 | RoW | AUR107 | Aurigene Discovery Technologies Limited | Relapsed Malignant Solid Neoplasm | 06/25 | 06/27 | | |
ASHA-1, NCT05984147: A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas |
|
|
| Recruiting | 1 | 40 | RoW | AUR108 | Aurigene Discovery Technologies Limited | Relapsed Advanced Lymphomas | 08/25 | 08/27 | | |
BHARAT-1, NCT05607199: A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics |
|
|
| Recruiting | 1 | 80 | RoW | AUR103, AUR 103 Calcium | Aurigene Discovery Technologies Limited | Solid Tumor, Adult, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non Hodgkin Lymphoma | 09/25 | 10/26 | | |
STAND, NCT04835428: - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients with Vertebral Compression Fractures |
|
|
| Recruiting | N/A | 408 | US | Treatment Group: AGN1 LOEP SV Kit, Control Group: PMMA bone cement | AgNovos Healthcare, LLC | Vertebral Compression Fracture, Compression Fracture, Vertebral Compression | 12/25 | 12/27 | | |
SYN 20-01, NCT05094089: Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application |
|
|
| Recruiting | N/A | 320 | Europe, US | Hernia repair with mesh | W.L.Gore & Associates | Hernia, Ventral, Hernia Incisional, Hernia Incisional Ventral | 12/25 | 12/28 | | |
